In this debut episode of Care Forward, we explore how artificial intelligence is revolutionizing cardiac procedures through the remarkable story of Volta Medical, a pioneering healthcare startup from Marseille, France.

I will take you deep into the world of atrial fibrillation (AF), a cardiac condition affecting 37 million patients worldwide. We learn how Volta Medical's groundbreaking AI software, AF-Xplorer, is transforming traditional cardiac ablation procedures by providing electrophysiologists with real-time guidance, increasing success rates from 50-60% to 88%.

The episode covers the company's journey from its founding in 2016 to securing major partnerships with GE Healthcare, highlighting both their unprecedented clinical trial results and the challenges they face in scaling their innovation.

This episode offers valuable insights into how the convergence of clinical expertise and cutting-edge technology can revolutionize patient care. It is also a rare example of flawless execution, from company creation up until clinical trial results publication in the most prestigious medical journal, Nature Medicine. Join us to understand the future of AI-guided medical procedures and the potential for breakthrough healthcare innovations to emerge from unexpected places.

👉 Full Show Notes: https://bit.ly/4k3i4Xk

-----

About Care Forward:

Care Forward takes you behind the scenes of healthcare's most promising breakthroughs. Join host Nina Bufi, a healthcare innovation expert, as she explores the technologies and innovators transforming patient care. Through in-depth analysis and compelling storytelling, each episode examines how cutting-edge solutions are addressing today's medical challenges. New episodes released every two weeks.

Connect with us on LinkedIn

Support Care Forward: If you enjoyed this episode, please follow us and share with others passionate about healthcare innovation. Your support helps us continue bringing these important stories to light.

Hosted on Ausha. See ausha.co/privacy-policy for more information.